Video Series: Our Team
Health Topics: Cancer
Shana is an oncologist in the Leukemia/Lymphoma Program at Children's National.
When Joey was 10-years-old, he was sent to Children's National and diagnosed with leukemia. Today, Joey is 16-years-old and cancer-free. He is enjoying his junior year of high school and playing baseball.
Read More of Joey's Story
Invest in future cures for some of life's most devastating diseases
With exclusive access to new treatments, the Experimental Therapeutics Program at Children’s National offers renewed hope for a good outcome to all families.
Cellular therapy is a novel treatment for reducing infection and relapse in children with blood cancers.
A $1.92 million grant from the National Institutes of Health (NIH) was awarded to a research team that focuses on new approaches for treatment of relapsed pediatric acute myelogenous leukemia (AML).
Leukemia is the most common form of pediatric cancer. It affects approximately 3,250 children each year in the US, accounting for about 30 percent of childhood cancers. It can occur at any age, although it is most commonly seen in children between 2 and 6 years of age.